Linear regression analyses showed no significant relationship between non-tumour absorbed dose (Gy) based on the whole liver volume and percent change in bilirubin (3.21, 95% CI: -1.17–7.61, p = 0.15), albumin (3.73 (-0.80–8.25, p = 0.10), aspartate aminotransferase (AST) (-0.69, 95% CI: -5.54–4.16, p = 0.77), alanine aminotransferase (2.74, 95% CI: -3.56–9.03, p = 0.38), alkaline phosphatase (4.47, 95% CI: -1.68–10.62, p = 0.15) and INR (1.95, 95% CI:-5.18–9.09, p = 0.58). The gene discussed is ALB; the disease is neoplasm.